Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, trips or professional assistance by using a real doctor. We are not physicians. Always consult your doctor about Philadelphia Chromosome Positive Chronic Myelogenous Leukemia conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical research trials and Philadelphia Chromosome Positive Chronic Myelogenous Leukemia health trials happen in many of cities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually assess the effectualness of new drugs. The intent of the studies / projects is to figure out certain human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector companies to locate cures for all sorts of conditions, such as Philadelphia Chromosome Positive Chronic Myelogenous Leukemia. Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trials and other clinical trials permit volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants undergo treatment for free, and occasionally they are compensated for their time. Occasionally there is a cost for a Philadelphia Chromosome Positive Chronic Myelogenous Leukemia clinical trial. Test subjects often obtain the finest healthcare possible for their Philadelphia Chromosome Positive Chronic Myelogenous Leukemia problem. Risks are a reality, however, and can include additional or frequent mD calls, healthcare risks (perhaps life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.

Home > Clinical Trials by Conditions > "P" Clinical Trial Conditions > Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trials

Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trials



AG-858 and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Were Previously Treated With Imatinib Mesylate
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Condition: h_lee_moffitt_cancer_center_and_research_institute_clinical_trials.html
H. Lee Moffitt Cancer Center and Research Institute

Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Chemotherapy and Filgrastim Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Condition: university_of_minnesota_cancer_center_clinical_trials.html
University of Minnesota Cancer Center

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
Condition: university_of_maryland_greenebaum_cancer_center_clinical_trials.html
University of Maryland Greenebaum Cancer Center

Chemotherapy, Biological Therapy, and/or Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Condition: iii_medizinische_klinik_mannheim_clinical_trials.html
III. Medizinische Klinik Mannheim

Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Condition: german_cml_study_group_clinical_trials.html
German CML Study Group

Chemotherapy, Low-Dose Total-Body Irradiation, and Peripheral Stem Cell Transplantation Followed By Chemotherapy and Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
Condition: fred_hutchinson_cancer_research_center_clinical_trials.html
Fred Hutchinson Cancer Research Center

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Condition: herbert_irving_comprehensive_cancer_center_clinical_trials.html
Herbert Irving Comprehensive Cancer Center

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Cyclophosphamide and Filgrastim Followed By Peripheral Stem Cell Transplantation in Treating Patients With Chronic or Accelerated Phase Myelogenous Leukemia
Condition: university_of_minnesota_cancer_center_clinical_trials.html
University of Minnesota Cancer Center

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
Condition: fred_hutchinson_cancer_research_center_clinical_trials.html
Fred Hutchinson Cancer Research Center

Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon alfa
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Homoharringtonine in Treating Patients With Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Condition: barbara_ann_karmanos_cancer_institute_clinical_trials.html
Barbara Ann Karmanos Cancer Institute

Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
Condition: commissie_voor_klinisch_toegepast_onderzoek_clinical_trials.html
Commissie Voor Klinisch Toegepast Onderzoek

Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Condition: oregon_health_and_science_university_clinical_trials.html
Oregon Health and Science University

Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Condition: childrens_oncology_group_clinical_trials.html
Children's Oncology Group

Imatinib Mesylate With or Without Cytarabine or PEG-Interferon alfa-2a in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group

Interferon alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
Condition: medical_research_council_clinical_trials.html
Medical Research Council

Interferon alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Condition: johns_hopkins_oncology_center_clinical_trials.html
Johns Hopkins Oncology Center

Oblimersen Plus Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Condition: cancer_and_leukemia_group_b_clinical_trials.html
Cancer and Leukemia Group B

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Condition: sidney_kimmel_cancer_center_clinical_trials.html
Sidney Kimmel Cancer Center

Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment
Condition: comprehensive_cancer_center_of_wake_forest_university_clinical_trials.html
Comprehensive Cancer Center of Wake Forest University

STI571 in Treating Patients With Recurrent Leukemia
Condition: childrens_oncology_group_clinical_trials.html
Children's Oncology Group

STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
Condition: shire_pharmaceutical_development_clinical_trials.html
Shire Pharmaceutical Development

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
Condition: university_of_connecticut_clinical_trials.html
University of Connecticut



Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trials

Modify your Search

Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Clinical Trials by State:

Alabama
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin

Other "P" Clinical Trials Conditions:

Paget's Disease Of Bone
Paget's Disease Of The Breast
Pain
Pancreatic Ca
Pancreatic Cancer
Pancreatic Diseases
Pancreatic Insufficiency
Pancreatic Islet Cell Tumor
Pancreatic Neoplasm
Pancreatic Neoplasms
Pancreatitis
Pancreatitis, Acute Necrotizing
Pancytopenia
Panic Disorder
Papilledema
Papilloma
Papovaviridae Infection
Paralysis
Paralysis, Hyperkalemic Periodic
Paramyotonia Congenita
Paranasal Sinus And Nasal Cavity Cancer
Paranoia
Paraplegia
Paraproteinemias
Parasitic Disease
Parasitic Intestinal Disease
Parathyroid Neoplasm
Parathyroid Neoplasms
Parenteral Nutrition
Paresthesia
Parkinson Disease
Parkinson's Disease
Parkinsonism
Paroxysmal Hemoglobinuria
Paroxysmal Hemoglobinuria, Nocturnal
Partial Epilepsy
Partial Hearing Loss
Partial Seizures
Passive-Aggressive Personality Disorder
Pathologic Angiogenesis
Pathologic Neovascularization
Patient Satisfaction
Pediatric Germ Cell Tumor
Pediatric Heart Disease
Pelvic Cancer
Pelvic Neoplasms
Pelvic Pain
Pemphigus
Pemphigus Vulgaris
Penile Squamous Cell Carcinoma
Peptic Ulcer Hemorrhage
Percutaneous Coronary Intervention
Peridontal Disease
Perimenopause
Periodic Disease
Periodontal Disease
Periodontitis
Perioperative And Postoperative Complications
Perioperative/postoperative Complications
Peripheral Nervous System Disease
Peripheral Nervous System Diseases
Peripheral Neuropathy
Peripheral T Cell Lymphoma
Peripheral T-Cell Lymphoma
Peripheral Vascular Disease
Peripheral Vascular Diseases
Peritoneal Cancer
Peritoneal Cavity Cancer
Peritoneal Neoplasm
Peritoneal Neoplasms
Peritonitis
Periventricular Leukomalacia
Peroxisomal Disorders
Persian Gulf Syndrome
Persistent Fetal Circulation Syndrome
Persistent Or Recurrent Ovarian Cancer
Personality Disorders
Pertussis
Pervasive Child Development Disorders
Pervasive Development Disorders
Pharyngeal Neoplasm
Phenylketonuria
Pheochromocytoma
Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Phobic Disorders
Phonation Disorder
Phosphorus Metabolism
Phyllodes Tumor
Physical Activity
Physician's Practice Patterns
Physician-Patient Relations
Pigment Dispersion Syndrome
Pituitary Disease
Pituitary Neoplasm
Pituitary Tumor
Plaque Psoriasis
Plasma Cell Dyscrasia
Plasma Cell Neoplasm
Plasma Cell Tumor
Plasma Cell Tumors
Plasmapheresis
Plasmodium Falciparum Malaria
Platelet Storage Pool Deficiency
Plexiform Neurofibroma
Pneumococcal Infections
Pneumoconiosis
Pneumocystis Carinii Infections
Pneumocystis Carinii Pneumonia
Pneumonia
Pneumonia, Aspiration
Pneumonia, Bacterial
Pneumonia, Pneumococcal
Pneumonia, Pneumocystis Carinii
Pneumonitis
Pneumothorax
Poisoning
Poliomyelitis
Polyarteritis Nodosa
Polycyclic Hydrocarbons, Aromatic
Polycystic Kidney, Autosomal Recessive
Polycystic Ovary Syndrome
Polycythemia Vera
Polymyositis
Polyneuropathies
Polyostotic Fibrous Dysplasia
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Pompe Disease
Poor Glycemic Control
Porphyria
Porphyria Cutanea Tarda
Porphyria, Erythropoietic
Portal Hypertension
Post Nephrectomy
Post Transplant Proteinuria
Post Traumatic Stress Disorder
Post-Transplant Lymphoproliferative Disorder
Post-Traumatic Seizure Disorder
Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorders
Postdiscectomy Epidural Fibrosis
Posterior Urethral Cancer
Postherpetic Neuralgia
Postlaminectomy Syndrome
Postmenopause
Postoperative Complications
Postpartum Depression
Postpartum Period
Postpoliomyelitis Syndrome
Poststroke Spasticity
Posttraumatic Stress Disorder
Postural Stability
Postural Tachycardia Syndrome
Pouchitis
Practice Guidelines
Prader-Willi Syndrome
Pre-Eclampsia
Precancerous Condition
Precancerous Conditions
Precocious Puberty
Prediabetic State
Pregnancy
Pregnancy Complications, Infectious
Premature Birth
Premature Ovarian Failure
Prematurity
Premenstrual Syndrome
Prenatal Care
Pressure Ulcers
Prevention Of Bladder Cancer
Prevention Of Breast Cancer
Prevention Of Cervical Cancer
Prevention Of Colorectal Cancer
Prevention Of Esophageal Cancer
Prevention Of Lung Cancer
Prevention Of Oral Cancer
Prevention Of Prostate Cancer
Prevention Of Skin Cancer
Previously Treated Childhood Rhabdomyosarcoma
Previously Treated Myelodysplastic Syndrome
Previously Treated Myelodysplastic Syndromes
Previously Untreated Childhood Rhabdomyosarcoma
Primary Central Nervous System Lymphoma
Primary Ciliary Dyskinesia
Primary Lateral Sclerosis
Primary Peritoneal Cancer
Primary Peritoneal Carcinoma
Primary Systemic Amyloidosis
Progressive Hairy Cell Leukemia, Initial Treatment
Progressive Multifocal Leukoencephalopathy
Progressive Supranuclear Palsy
Proliferative Vitreoretinopathy
Prolymphocytic Leukemia
Prostate Ca
Prostate Cancer
Prostate Disease
Prostate Neoplasm
Prostate Neoplasms
Prostatic Hyperplasia
Prostatic Hypertrophy, Benign
Prostatic Intraepithelial Neoplasia
Prostatic Neoplasm
Prostatic Neoplasms
Protein-Energy Malnutrition
Proteinuria
Protozoan Infections
Pruritus
Pseudohypoaldosteronism
Pseudohypoparathyroidism
Pseudomonas Infection
Pseudomonas Infections
Pseudopseudohypoparathyroidism
Pseudotumor Cerebri
Psoriasis
Psoriatic Arthritis
Psychomotor Agitation
Psychopathology
Psychoses
Psychosis
Psychosocial Effects And Treatment
Psychosocial Effects/treatment
Psychotic Disorder
Psychotic Disorders
Public Speaking Anxiety
Pulmonary Alveolar Proteinosis
Pulmonary Arterial Hypertension
Pulmonary Atresia
Pulmonary Cancer
Pulmonary Carcinoid Tumor
Pulmonary Complications
Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
Pulmonary Edema
Pulmonary Embolism
Pulmonary Emphysema
Pulmonary Fibrosis
Pulmonary Hypertension
Pulmonary Metastases
Pulmonary Neoplasms
Pulmonary Sarcoidosis
Pulmonary Tuberculosis
Pulmonary Valve Stenosis
Pulmonic Stenosis
Pure Red Cell Aplasia
Pure Red-Cell Aplasia
Purine-Pyrimidine Metabolism, Inborn Errors
Purpura, Schoenlein-Henoch
Purpura, Thrombocytopenic
Purpura, Thrombocytopenic, Idiopathic


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103